Escitalopram: a review of its use in the management of anxiety disorders.
about
Next-step strategies for panic disorder refractory to initial pharmacotherapy: a 3-phase randomized clinical trial.Escitalopram in obsessive-compulsive disorder: a case series.Escitalopram for the management of major depressive disorder: a review of its efficacy, safety, and patient acceptability.Effect of age, weight, and CYP2C19 genotype on escitalopram exposure.Effects of reboxetine and citalopram on appraisal of infant facial expressions and attentional biases.The use of escitalopram beyond major depression: pharmacological aspects, efficacy and tolerability in anxiety disorders.Escitalopram for the treatment of major depression and anxiety disorders.Analysis of health-related quality of life and costs based on a randomised clinical trial of escitalopram for relapse prevention in patients with generalised social anxiety disorder.Clinically significant drug interactions with newer antidepressants.Antidepressant treatment and emotional processing: can we dissociate the roles of serotonin and noradrenaline?New treatment options for OCD.An emerging role for escitalopram in the treatment of obsessive-compulsive disorder.Efficacy, effectiveness and efficiency of escitalopram in the treatment of major depressive and anxiety disorders.The importance of serotonin and noradrenaline in anxiety.Therapeutic implications of adding the psychotropic drug escitalopram in the treatment of patients suffering from moderate-severe psoriasis and psychiatric comorbidity: a retrospective study.Highly Enantioselective Rhodium-Catalyzed Addition of Arylboroxines to Simple Aryl Ketones: Efficient Synthesis of Escitalopram.
P2860
Q34369492-D6A33CCF-D48A-4B42-9617-FE65AB755CACQ36274266-EDAB32B4-EFEB-4E4A-8102-8859E6EB406CQ36479510-3390016C-86E2-431B-94EB-FCE2A45070E0Q36606190-3F8D9466-5DC7-4D6A-BD45-374C4BCA17A8Q36613432-AF91DF93-47B6-4466-B4FD-5B259EB38B2DQ36960563-1D766650-04FE-42D3-ACB8-1ECBBFA930BCQ37139768-DE74EAAB-3CAE-479B-8577-8B0A64BBCFEDQ37248330-AEF0071D-887F-413F-9EAF-3EFA977E121EQ37968621-2CDCE44E-F9D3-4AAA-B648-C8E41B4B9F7BQ38080019-BE66553D-40A8-47E9-A228-7EA228016481Q39341666-6AC67E06-5D3D-4219-9EBC-62DEBE4DB053Q41981820-04EF5D3F-E3C1-485B-B1E3-B1E2EA934D29Q43042829-E2E7820E-F01E-470D-896E-D8FF76C25F91Q48324468-23D8FC9A-A15B-467F-A74D-66E372ADECFBQ48614699-EBBB90B6-E535-4248-9B53-4CBFFBB84DFFQ53161348-93503864-2BFD-42F7-92D5-FA1CCFB7335E
P2860
Escitalopram: a review of its use in the management of anxiety disorders.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Escitalopram: a review of its use in the management of anxiety disorders.
@ast
Escitalopram: a review of its use in the management of anxiety disorders.
@en
type
label
Escitalopram: a review of its use in the management of anxiety disorders.
@ast
Escitalopram: a review of its use in the management of anxiety disorders.
@en
prefLabel
Escitalopram: a review of its use in the management of anxiety disorders.
@ast
Escitalopram: a review of its use in the management of anxiety disorders.
@en
P1433
P1476
Escitalopram: a review of its use in the management of anxiety disorders.
@en
P2093
Sohita Dhillon
P304
P356
10.2165/00023210-200620090-00010
P577
2006-01-01T00:00:00Z
P6179
1015159648